we established an in-vitro perifusion system to examine the release of crf from perifused hypothalami taken from fetuses at day 100 and day 140 of pregnancy , under basal conditions and in response to potassium depolarization and/or dexamethasone administration .
C0010132
crf
C0020663
hypothalami